Autonomix Medical Inc. has been granted a new U.S. patent for its cutting-edge catheter-based platform technology, enhancing its position as a leader in medical device technology.

Autonomix Medical, a Nasdaq-listed company, is navigating financial challenges while maintaining its commitment to innovation and strategic maneuvers to sustain its market presence.